Recurium Equity, LLC 4
4 · Zentalis Pharmaceuticals, Inc. · Filed Oct 30, 2020
Insider Transaction Report
Form 4Exit
Recurium Equity, LLC
10% Owner
Transactions
- Other
Common Stock
[F1]2020-10-28−4,147,940→ 14,990 total
Footnotes (1)
- [F1]Recurium Equity, LLC distributed these shares to its members on a pro rata basis, for no consideration.
Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Recurium Equity, LLC|2020-10-30